Mitra Rafiee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mitra Rafiee has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Andrã© Luis Souza Santos
Universidade Federal do Rio de Janeiro (UFRJ)
3 shared publications - Fatemeh Nikoomanesh
Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran
3 shared publications - Celia Fortuna Rodrigues
Associate Laboratory i4HB - Institute for Health and Bioeconomy, University Institute of Health Sciences - CESPU, Gandra, Portugal
2 shared publications - Fahimeh Ghasemi
Cellular and Molecular Research Centre and Department of Medical Biotechnology, Faculty of Medicine Birjand University of Medical Sciences Birjand Iran
2 shared publications - Lucia Černáková
Department of Microbiology and Virology, Faculty of Natural Sciences, Comenius University in Bratislava, Ilkovičova 6, 84215 Bratislava, Slovakia
2 shared publications - Mahsa Falahatinejad
Department of Medical Mycology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran 14115111, Iran
2 shared publications
Latest Publications
- 18 June 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1)
Lawsone modulates oxidative stress, apoptosis, and enhances growth factor expression in human dermal fibroblasts under hyperglycemic conditions
Delayed wound healing is a serious issue in diabetes, which is driven by metabolic and non-metabolic factors. Dysfunction and decreased lifespan of fibroblast cells play a key role in this condition. Lawsone (2-hydroxy-1,4-naphthoquinone), the main active component of Lawsonia inermis, is well known for its anticancer and regenerative effects, although these effects vary depending on concentration and experimental conditions. Regarding the importance of Diabetic wound treatment, this study examines how lawsone affects fibroblast behavior under high-glucose conditions, focusing on cell viability, apoptosis, intracellular Reactive Oxygen Species (ROS) levels, migration, and the expression of repair-related genes Nerve Growth Factor (NGF) and Transforming Growth Factor-beta (TGF-β). Human dermal fibroblasts were cultured under high-glucose (85-140mM) conditions, in the presence or absence of lawsone (10µg/mL). The MTT assay assessed cell viability, migration by the scratch assay, apoptosis by Annexin V- Fluorescein Isothiocyanate/Propidium Iodide (FITC/PI) flow cytometry, and ROS levels by 2',7'-dichlorodihydrofluorescein diacetate (H₂DCFDA) staining. quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) was used to quantify NGF and TGF-β mRNA expression. High glucose significantly impaired fibroblast viability and migration, increased apoptosis and ROS production, and downregulated TGF-β expression. Co-treatment with lawsone markedly restored cell viability and migration, suppressed oxidative stress and apoptosis, and enhanced NGF and TGF-β transcription, indicating reactivation of reparative pathways (p ≤ 0.05). Lawsone exhibits potent cytoprotective and pro-regenerative effects in human dermal fibroblasts under hyperglycemic stress, independent of its known anticancer activity. These findings highlight lawsone as a natural candidate for promoting diabetic wound healing and warrant further mechanistic and in vivo investigations.
- 18 June 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1)
Lawsone modulates oxidative stress, apoptosis, and enhances growth factor expression in human dermal fibroblasts under hyperglycemic conditions
Delayed wound healing is a serious issue in diabetes, which is driven by metabolic and non-metabolic factors. Dysfunction and decreased lifespan of fibroblast cells play a key role in this condition. Lawsone (2-hydroxy-1,4-naphthoquinone), the main active component of Lawsonia inermis, is well known for its anticancer and regenerative effects, although these effects vary depending on concentration and experimental conditions. Regarding the importance of Diabetic wound treatment, this study examines how lawsone affects fibroblast behavior under high-glucose conditions, focusing on cell viability, apoptosis, intracellular Reactive Oxygen Species (ROS) levels, migration, and the expression of repair-related genes Nerve Growth Factor (NGF) and Transforming Growth Factor-beta (TGF-β). Human dermal fibroblasts were cultured under high-glucose (85-140mM) conditions, in the presence or absence of lawsone (10µg/mL). The MTT assay assessed cell viability, migration by the scratch assay, apoptosis by Annexin V- Fluorescein Isothiocyanate/Propidium Iodide (FITC/PI) flow cytometry, and ROS levels by 2',7'-dichlorodihydrofluorescein diacetate (H₂DCFDA) staining. quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) was used to quantify NGF and TGF-β mRNA expression. High glucose significantly impaired fibroblast viability and migration, increased apoptosis and ROS production, and downregulated TGF-β expression. Co-treatment with lawsone markedly restored cell viability and migration, suppressed oxidative stress and apoptosis, and enhanced NGF and TGF-β transcription, indicating reactivation of reparative pathways (p ≤ 0.05). Lawsone exhibits potent cytoprotective and pro-regenerative effects in human dermal fibroblasts under hyperglycemic stress, independent of its known anticancer activity. These findings highlight lawsone as a natural candidate for promoting diabetic wound healing and warrant further mechanistic and in vivo investigations.
- Open Access
- 1 June 2026
- Published by InkVista Publishing House
- Vol. 33 (2) , 86-98
A review on the process immune system's interaction with mycobiota and pathogenic fungi
In recent years, the role of mycobiota as a fungal component of the human microbiota and its complex interactions with the immune system have become a major focus of immunology and infectious disease research. Increasing evidence suggests that mycobiota, in addition to maintaining mucosal homeostasis, plays a fundamental role in inducing immune tolerance, ...
- 1 June 2026
- Published by InkVista Publishing House
- Vol. 33 (2) , 86-98
Open AccessA review on the process immune system's interaction with mycobiota and pathogenic fungi
In recent years, the role of mycobiota as a fungal component of the human microbiota and its complex interactions with the immune system have become a major focus of immunology and infectious disease research. Increasing evidence suggests that mycobiota, in addition to maintaining mucosal homeostasis, plays a fundamental role in inducing immune tolerance, ...
- Open Access
- 1 January 2026
- Published by Wiley in International Journal of Microbiology
- Vol. 2026 (1)
Lactobacillus acidophilus and Lacticaseibacillus rhamnosus Postbiotics Attenuate Keratinocyte Hyperproliferation and Oxidative Stress and Promote Apoptosis: Potential Implications for Psoriasis
Objectives: Keratinocytes are essential for skin integrity and actively regulate inflammation in a chronic autoimmune condition marked by excessive skin cell growth and an aberrant immune response. The progression of such a disease is driven by oxidative stress and cytokine release, complicating treatment strategies. This research explored the potential of postbiotics derived from Lactobacillus acidophilus and Lacticaseibacillus rhamnosus as therapeutic agents, evaluating their effects on keratinocyte proliferation, migration, reactive oxygen species (ROS) levels, and apoptosis compared to the control group. Methods: HaCaT cells were cultured in DMEM (Dulbecco′s Modified Eagle Medium) and treated with postbiotics from two bacterial strains. MTT (3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyl tetrazolium bromide) assays were used to assess cell viability, scratch assays evaluated cell migration, and Annexin V/PI (propidium iodide) staining analyzed apoptosis. Additionally, ROS levels were quantified via flow cytometry following postbiotic treatment. Results: Both postbiotics significantly reduced HaCaT cell viability, increased apoptosis, inhibited cell migration, and decreased ROS levels ( p < 0.05). Conclusion: By significantly reducing keratinocyte proliferation and migration while inducing apoptosis, these specific postbiotics showed potential for further investigation as candidates for managing skin disorders.
- 1 January 2026
- Published by Wiley in International Journal of Microbiology
- Vol. 2026 (1)
Open AccessLactobacillus acidophilus and Lacticaseibacillus rhamnosus Postbiotics Attenuate Keratinocyte Hyperproliferation and Oxidative Stress and Promote Apoptosis: Potential Implications for Psoriasis
Objectives: Keratinocytes are essential for skin integrity and actively regulate inflammation in a chronic autoimmune condition marked by excessive skin cell growth and an aberrant immune response. The progression of such a disease is driven by oxidative stress and cytokine release, complicating treatment strategies. This research explored the potential of postbiotics derived from Lactobacillus acidophilus and Lacticaseibacillus rhamnosus as therapeutic agents, evaluating their effects on keratinocyte proliferation, migration, reactive oxygen species (ROS) levels, and apoptosis compared to the control group. Methods: HaCaT cells were cultured in DMEM (Dulbecco′s Modified Eagle Medium) and treated with postbiotics from two bacterial strains. MTT (3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyl tetrazolium bromide) assays were used to assess cell viability, scratch assays evaluated cell migration, and Annexin V/PI (propidium iodide) staining analyzed apoptosis. Additionally, ROS levels were quantified via flow cytometry following postbiotic treatment. Results: Both postbiotics significantly reduced HaCaT cell viability, increased apoptosis, inhibited cell migration, and decreased ROS levels ( p < 0.05). Conclusion: By significantly reducing keratinocyte proliferation and migration while inducing apoptosis, these specific postbiotics showed potential for further investigation as candidates for managing skin disorders.
- Open Access
- 1 June 2025
- Published by MDPI AG in Journal of Fungi
- Vol. 11 (6) , 427
Exploring the Antifungal Potential of Lawsone-Loaded Mesoporous Silica Nanoparticles Against Candida albicans and Candida glabrata: Growth Inhibition and Biofilm Disruption
The incidence of fungal infections is significantly rising, posing a challenge due to the limited class of antifungal drugs. There is a necessity to combat emerging resistant fungal infections by developing novel antifungal agents. This study aimed to evaluate the antifungal effects of lawsone (LAW), a natural component extracted from herbal medicine, and LAW-loaded mesoporous silica nanoparticles (LAW-MSNs) on growth, biofilm formation, and expression of ALS1 and EPA1 genes contributing to cell adhesion of Candida spp. Twenty C. albicans and twenty C. glabrata isolates, including ten fluconazole-resistant and ten fluconazole-susceptible isolates, were examined. The findings of the study indicated that LAW and LAW-MSNs inhibited Candida isolates growth at MIC range of 0.31–>5 µg/mL and significantly reduced biofilm formation in C. albicans and C. glabrata. Moreover, both LAW and LAW-MSNs downregulated the expression of the adhesion genes ALS1 and EPA1 in C. albicans and C. glabrata. Based on the obtained findings, LAW emerged as a promising antifungal candidate. However, the nano-formulation (LAW-MSNs) improved its antifungal properties.
- 1 June 2025
- Published by MDPI AG in Journal of Fungi
- Vol. 11 (6) , 427
Open AccessExploring the Antifungal Potential of Lawsone-Loaded Mesoporous Silica Nanoparticles Against Candida albicans and Candida glabrata: Growth Inhibition and Biofilm Disruption
The incidence of fungal infections is significantly rising, posing a challenge due to the limited class of antifungal drugs. There is a necessity to combat emerging resistant fungal infections by developing novel antifungal agents. This study aimed to evaluate the antifungal effects of lawsone (LAW), a natural component extracted from herbal medicine, and LAW-loaded mesoporous silica nanoparticles (LAW-MSNs) on growth, biofilm formation, and expression of ALS1 and EPA1 genes contributing to cell adhesion of Candida spp. Twenty C. albicans and twenty C. glabrata isolates, including ten fluconazole-resistant and ten fluconazole-susceptible isolates, were examined. The findings of the study indicated that LAW and LAW-MSNs inhibited Candida isolates growth at MIC range of 0.31–>5 µg/mL and significantly reduced biofilm formation in C. albicans and C. glabrata. Moreover, both LAW and LAW-MSNs downregulated the expression of the adhesion genes ALS1 and EPA1 in C. albicans and C. glabrata. Based on the obtained findings, LAW emerged as a promising antifungal candidate. However, the nano-formulation (LAW-MSNs) improved its antifungal properties.
- Open Access
- 1 January 2025
- Published by Wiley in Dermatology Research and Practice
- Vol. 2025 (1) , 9764336
Thymoquinone Inhibits Proliferation and Induces Apoptosis in Immortalized Keratinocytes via Upregulation of p53 Expression
Introduction: Psoriasis, as a common inflammatory skin disease, is characterized by hyperproliferation of epidermal keratinocytes and induction of an inflammatory response. Apoptosis induction and prevention of the proliferation of keratinocytes can help to treat and manage this disease. Thymoquinone (TQ), a bioactive compound with antioxidant and anti‐inflammatory properties, has also been reported as a natural antitumor agent. This study aimed to evaluate the effects of TQ on proliferation and apoptosis in human keratinocyte cells (HaCaT). Methods: HaCaT cells were treated with increasing concentrations of TQ (1, 2, 4, 6, 8, 16, 32, and 64 μg/mL), and cell viability was assessed using the MTT assay. Apoptosis was analyzed via flow cytometry using Annexin V‐FITC/PI staining. Expression levels of p53, Bax, and BCL‐xl genes were measured by real‐time PCR. Results: TQ significantly reduced cell viability in a dose‐dependent manner, with an IC50 of 11.64 μg/mL after 72 h. Flow cytometry revealed a marked increase in early apoptotic cells following treatment with 8 μg/mL TQ (41.00% ± 5.04%) compared to control (17.8% ± 2.26%, P ≤ 0.001). Gene expression analysis showed significant upregulation of p53, while Bax and BCL‐xl levels showed no significant changes. Conclusion: TQ induces apoptosis in human HaCaT cells primarily through p53‐dependent pathways, suggesting its potential as a therapeutic agent for skin‐related disorders .
- 1 January 2025
- Published by Wiley in Dermatology Research and Practice
- Vol. 2025 (1) , 9764336
Open AccessThymoquinone Inhibits Proliferation and Induces Apoptosis in Immortalized Keratinocytes via Upregulation of p53 Expression
Introduction: Psoriasis, as a common inflammatory skin disease, is characterized by hyperproliferation of epidermal keratinocytes and induction of an inflammatory response. Apoptosis induction and prevention of the proliferation of keratinocytes can help to treat and manage this disease. Thymoquinone (TQ), a bioactive compound with antioxidant and anti‐inflammatory properties, has also been reported as a natural antitumor agent. This study aimed to evaluate the effects of TQ on proliferation and apoptosis in human keratinocyte cells (HaCaT). Methods: HaCaT cells were treated with increasing concentrations of TQ (1, 2, 4, 6, 8, 16, 32, and 64 μg/mL), and cell viability was assessed using the MTT assay. Apoptosis was analyzed via flow cytometry using Annexin V‐FITC/PI staining. Expression levels of p53, Bax, and BCL‐xl genes were measured by real‐time PCR. Results: TQ significantly reduced cell viability in a dose‐dependent manner, with an IC50 of 11.64 μg/mL after 72 h. Flow cytometry revealed a marked increase in early apoptotic cells following treatment with 8 μg/mL TQ (41.00% ± 5.04%) compared to control (17.8% ± 2.26%, P ≤ 0.001). Gene expression analysis showed significant upregulation of p53, while Bax and BCL‐xl levels showed no significant changes. Conclusion: TQ induces apoptosis in human HaCaT cells primarily through p53‐dependent pathways, suggesting its potential as a therapeutic agent for skin‐related disorders .
- 23 March 2024
- Published by Springer Nature in Molecular Biology Reports
- Vol. 51 (1) , 1-8
CTLA-4 expression and polymorphisms in Schizophrenia; a systematic review of literature
Schizophrenia constitutes a severe psychiatric disorder with detrimental impacts on individuals, their support systems, and the broader economy. Extensive research has revealed a notable association between variations in the Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) gene and an increased susceptibility to schizophrenia. This study represents the first systematic review of the literature investigating the impact of CTLA-4 polymorphisms and expression on the development and progression of schizophrenia. Our investigation involved a comprehensive search strategy, using a combination of title, abstract, and MESH terms in four databases, including PubMed, Scopus, Web of Science, and Google Scholar, until August 29th, 2023. The complete texts of the identified records were obtained and rigorously assessed based on predefined exclusion and inclusion criteria. Out of the numerous records, a total of 88 were identified through the databases. 10 studies met the criteria; therefore, their quality was assessed and included in this systematic study. The records were then categorized into polymorphism and expression groups. Our investigation emphasizes an association between rs3087243, rs231779, rs231777, rs16840252, rs5742909, and rs231775 polymorphisms and the development of schizophrenia. The results demonstrate a correlation between CTLA-4 polymorphisms and schizophrenia, compelling the need for further research to thoroughly examine the role of CTLA-4 in schizophrenia and other psychiatric disorders.
- 23 March 2024
- Published by Springer Nature in Molecular Biology Reports
- Vol. 51 (1) , 1-8
CTLA-4 expression and polymorphisms in Schizophrenia; a systematic review of literature
Schizophrenia constitutes a severe psychiatric disorder with detrimental impacts on individuals, their support systems, and the broader economy. Extensive research has revealed a notable association between variations in the Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) gene and an increased susceptibility to schizophrenia. This study represents the first systematic review of the literature investigating the impact of CTLA-4 polymorphisms and expression on the development and progression of schizophrenia. Our investigation involved a comprehensive search strategy, using a combination of title, abstract, and MESH terms in four databases, including PubMed, Scopus, Web of Science, and Google Scholar, until August 29th, 2023. The complete texts of the identified records were obtained and rigorously assessed based on predefined exclusion and inclusion criteria. Out of the numerous records, a total of 88 were identified through the databases. 10 studies met the criteria; therefore, their quality was assessed and included in this systematic study. The records were then categorized into polymorphism and expression groups. Our investigation emphasizes an association between rs3087243, rs231779, rs231777, rs16840252, rs5742909, and rs231775 polymorphisms and the development of schizophrenia. The results demonstrate a correlation between CTLA-4 polymorphisms and schizophrenia, compelling the need for further research to thoroughly examine the role of CTLA-4 in schizophrenia and other psychiatric disorders.
- Open Access
- 1 June 2023
- Published by Apex Publishing in Journal of Translational Medical Research
- Vol. 30 (1) , 107-113
Effect of berberine on the expression of membrane progesterone receptor (mPRβ) in NALM6 cells
Acute lymphoid leukemia (ALL) is a type of blood cancer associated with the malignant proliferation of lymphoid progenitor cells. In recent years, natural medicines have received attention due to reasons such as availability, fewer side effects, and lower costs. Berberine (BBR) is a bioactive compound with anticancer effects that influences progesterone production. ...
- 1 June 2023
- Published by Apex Publishing in Journal of Translational Medical Research
- Vol. 30 (1) , 107-113
Open AccessEffect of berberine on the expression of membrane progesterone receptor (mPRβ) in NALM6 cells
Acute lymphoid leukemia (ALL) is a type of blood cancer associated with the malignant proliferation of lymphoid progenitor cells. In recent years, natural medicines have received attention due to reasons such as availability, fewer side effects, and lower costs. Berberine (BBR) is a bioactive compound with anticancer effects that influences progesterone production. ...
- Open Access
- 20 April 2023
- Published by Springer Nature in BMC Research Notes
- Vol. 16 (1) , 1-4
CD33 as a leukocyte-associated marker expressed on human spermatozoa
Sialic acid-binding immunoglobulin-type lectins (Siglecs) are commonly present on immune cells and often mediate cell-to-cell interactions and signaling. Studies have shown the presence of Siglecs 1, 2, 5, 6, 10 and 14 on human spermatozoa. To the best of our knowledge, the expression of CD33 on spermatozoa has not yet been studied. Semen samples were collected from 25 healthy men with normal semen status. CD33 expression on purified spermatozoa was evaluated by flow cytometry methods. The results demonstrate the expression of CD33 on the surface of purified spermatozoa. The mean (± SD) of MFI (mean fluorescence intensity) was 12.85 (± 1.33) and the mean percentage of spermatozoa that express CD33 was 73.75 (± 3.75). Results were obtained showing that spermatozoa express CD33 (or Siglec-3) on their surface. The physiological role of these molecules on spermatozoa remains to be determined. It is recommended that further research be undertaken regarding the role of Siglecs (such as CD33) on spermatozoa apoptosis.
- 20 April 2023
- Published by Springer Nature in BMC Research Notes
- Vol. 16 (1) , 1-4
Open AccessCD33 as a leukocyte-associated marker expressed on human spermatozoa
Sialic acid-binding immunoglobulin-type lectins (Siglecs) are commonly present on immune cells and often mediate cell-to-cell interactions and signaling. Studies have shown the presence of Siglecs 1, 2, 5, 6, 10 and 14 on human spermatozoa. To the best of our knowledge, the expression of CD33 on spermatozoa has not yet been studied. Semen samples were collected from 25 healthy men with normal semen status. CD33 expression on purified spermatozoa was evaluated by flow cytometry methods. The results demonstrate the expression of CD33 on the surface of purified spermatozoa. The mean (± SD) of MFI (mean fluorescence intensity) was 12.85 (± 1.33) and the mean percentage of spermatozoa that express CD33 was 73.75 (± 3.75). Results were obtained showing that spermatozoa express CD33 (or Siglec-3) on their surface. The physiological role of these molecules on spermatozoa remains to be determined. It is recommended that further research be undertaken regarding the role of Siglecs (such as CD33) on spermatozoa apoptosis.
- Open Access
Combination of Farnesol with Common Antifungal Drugs: Inhibitory Effect against Candida Species Isolated from Women with RVVC
Background and Objectives: Vulvovaginal candidiasis (VVC) is a mucous membrane infection, with an increased rate of antifungal resistance of Candida species. In this study, the in vitro efficacy of farnesol alone or in combination with traditional antifungals was assessed against resistant Candida strains recovered from women with VVC. Materials and Methods: Eighty Candida isolates were identified by multiplex polymerase chain reaction (PCR), and the antifungal susceptibility to amphotericin B (AMB), fluconazole (FLU), itraconazole (ITZ), voriconazole (VOR), clotrimazole (CTZ), and farnesol was tested by the standard microdilution method. The combinations of farnesol with each antifungal were calculated based on the fractional inhibitory concentration index (FICI). Result: Candida glabrata was the predominant species (48.75%) isolated from vaginal discharges, followed by C. albicans (43.75%), C. parapsilosis (3.75%), a mixed infection of C. albicans and C. glabrata (2.5%) and C. albicans and C. parapsilosis (1%). C. albicans and C. glabrata isolates had lower susceptibility to FLU (31.4% and 23.0%, respectively) and CTZ (37.1% and 33.3%, respectively). Importantly, there was “synergism” between farnesol–FLU and farnesol–ITZ against C. albicans and C. parapsilosis (FICI = 0.5 and 0.35, respectively), reverting the original azole-resistant profile. Conclusion: These findings indicate that farnesol can revert the resistance profile of azole by enhancing the activity of FLU and ITZ in resistant Candida isolates, which is a clinically promising result.
Open AccessCombination of Farnesol with Common Antifungal Drugs: Inhibitory Effect against Candida Species Isolated from Women with RVVC
Background and Objectives: Vulvovaginal candidiasis (VVC) is a mucous membrane infection, with an increased rate of antifungal resistance of Candida species. In this study, the in vitro efficacy of farnesol alone or in combination with traditional antifungals was assessed against resistant Candida strains recovered from women with VVC. Materials and Methods: Eighty Candida isolates were identified by multiplex polymerase chain reaction (PCR), and the antifungal susceptibility to amphotericin B (AMB), fluconazole (FLU), itraconazole (ITZ), voriconazole (VOR), clotrimazole (CTZ), and farnesol was tested by the standard microdilution method. The combinations of farnesol with each antifungal were calculated based on the fractional inhibitory concentration index (FICI). Result: Candida glabrata was the predominant species (48.75%) isolated from vaginal discharges, followed by C. albicans (43.75%), C. parapsilosis (3.75%), a mixed infection of C. albicans and C. glabrata (2.5%) and C. albicans and C. parapsilosis (1%). C. albicans and C. glabrata isolates had lower susceptibility to FLU (31.4% and 23.0%, respectively) and CTZ (37.1% and 33.3%, respectively). Importantly, there was “synergism” between farnesol–FLU and farnesol–ITZ against C. albicans and C. parapsilosis (FICI = 0.5 and 0.35, respectively), reverting the original azole-resistant profile. Conclusion: These findings indicate that farnesol can revert the resistance profile of azole by enhancing the activity of FLU and ITZ in resistant Candida isolates, which is a clinically promising result.
- Open Access
- 5 January 2023
- Published by MDPI AG in Preprints.org
Combination of Farnesol with Common Antifungal Drugs: Inhibitory Effect against Clinical Isolates of Candida Species
Vulvovaginal candidiasis (VVC) is a mucous membrane infection, with an increased rate of antifungal resistance of Candida species. The in vitro efficacy of farnesol alone or in combination with traditional antifungals, against resistant Candida strains recovered from women with VVC was assessed. In this study, 80 Candida isolats were identified by multi-plex PCR. Antifungal sus-ceptibility of amphotericin B (AMB), fluconazole (FLU), itraconazole (ITZ), voriconazole (VOR), clotrimazole (CTZ) and farnesol was tested by M27-A3/S4 broth micro dilution method. The combinations of farnesol with each antifungal were calculated based on the fractional inhibitor concentration index (FICI). C. glabrata was the predominant species (48.75%) isolated from vaginal discharges, followed by C. albicans (43.75%), C. parapsilosis (3.75%), mixed infection of C. albicans and C. glabrata (2.5%), C. albicans and C. parapsilosis (1%). C. albicans and C. glabrata isolates had lower susceptibility to FLU (31.4% and 23.0%, respectively) and CTZ (37.1% and 33.3%, respectively). Importantly, there was ‟synergismˮ between farnesol-FLU and farnesol-ITZ against C. albicans and C. parapsilosis (FICI= 0.5 and 0.35, respectively), reverting the original azole resistant profile. These findings indicate that farnesol is able to revert to the resistance profile of azole by enhancing the activity of FLU and ITZ in resistant isolates, which is a promising result.
- 5 January 2023
- Published by MDPI AG in Preprints.org
Open AccessCombination of Farnesol with Common Antifungal Drugs: Inhibitory Effect against Clinical Isolates of Candida Species
Vulvovaginal candidiasis (VVC) is a mucous membrane infection, with an increased rate of antifungal resistance of Candida species. The in vitro efficacy of farnesol alone or in combination with traditional antifungals, against resistant Candida strains recovered from women with VVC was assessed. In this study, 80 Candida isolats were identified by multi-plex PCR. Antifungal sus-ceptibility of amphotericin B (AMB), fluconazole (FLU), itraconazole (ITZ), voriconazole (VOR), clotrimazole (CTZ) and farnesol was tested by M27-A3/S4 broth micro dilution method. The combinations of farnesol with each antifungal were calculated based on the fractional inhibitor concentration index (FICI). C. glabrata was the predominant species (48.75%) isolated from vaginal discharges, followed by C. albicans (43.75%), C. parapsilosis (3.75%), mixed infection of C. albicans and C. glabrata (2.5%), C. albicans and C. parapsilosis (1%). C. albicans and C. glabrata isolates had lower susceptibility to FLU (31.4% and 23.0%, respectively) and CTZ (37.1% and 33.3%, respectively). Importantly, there was ‟synergismˮ between farnesol-FLU and farnesol-ITZ against C. albicans and C. parapsilosis (FICI= 0.5 and 0.35, respectively), reverting the original azole resistant profile. These findings indicate that farnesol is able to revert to the resistance profile of azole by enhancing the activity of FLU and ITZ in resistant isolates, which is a promising result.